Although it is generally agreed that PKC activation contributes to cardiovascular dysfunction [128, 129], no consensus has been reached regarding the molecular basis of PKC upregulation in hyperglycemia or diabetes. This evidence concerns the gene PRRT2 and diabetes mellitus.